Blood Purification with oXiris© in Critically Ill Children with Vasoplegic Shock
Blood Purification · 2023
DOI: 10.1159/000530147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Purification, 2023. Verfasst von Luc Morin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Intensive Care and Neonatal Medicine, Bicêtre Hospital, AP-HP Paris Saclay University, Le Kremlin-Bicêtre, France. Hauptthemen laut MEDLINE: Acute Kidney Injury, Cardiovascular Agents, Sepsis, Shock, Septic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. As such, circulating cytokines and danger- and pathogen-associated molecular patterns (such as endotoxins) are recognized as central in the pathogenesis of sepsis and organ dysfunction. Removing these compounds by extracorporeal blood filtration, commonly considered blood purification, may improve the septic patients’ condition. This study aimed to assess the vaso-inotropic support evolution over time in pediatric patients with vasoplegic shock treated with oXiris©.
Methods
All patients aged below 18 years admitted at the Paris Saclay University Quaternary Pediatric Intensive Care Unit with vasoplegic shock and acute kidney injury and treated with oXiris© between October 2017 and January 2020 were included. The vaso-inotropic score and the 28-day mortality were assessed. Improvement under treatment was defined as a 50% decrease in the vaso-inotropic score following 24 h of oXiris© therapy.
Results
Eleven pediatric patients aged 2–15 years and weighing 11–60 kg were admitted with vasoplegic shock and acute kidney injury. They received thirteen sessions of oXiris© therapy for septic shock (N = 7) and liver failure (N = 6). Eight patients did not improve their condition during the session, and five ultimately died (37.5% survival). Five patients improved, decreasing their inotropic support by >50% in 24 h. Among them, four survived (80%).
Conclusion
Hemofiltration and extracorporeal blood purification with oXiris© can be used in pediatric patients with vasoplegic shock with rapid improvement in hemodynamics in selected patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Intensive Care and Neonatal Medicine, Bicêtre Hospital, AP-HP Paris Saclay University, Le Kremlin-Bicêtre, France.
- Institute of Integrative Biology of the Cell, CNRS, CEA, Paris Saclay University, Gif-sur-Yvette, France.
- FHU SEPSIS, AP-HP, Inserm, Paris Saclay University, Le Kremlin-Bicêtre, France.
Zitieren
APA
Morin, L., Charbel, R., Cousin, V. L., Marais, C., Claude, C., Barreault, S., Durand, P., Miatello, J., & Tissières, P. (2023). Blood Purification with oXiris© in Critically Ill Children with Vasoplegic Shock. Blood Purification. https://doi.org/10.1159/000530147
Vancouver
Morin L, Charbel R, Cousin VL, Marais C, Claude C, Barreault S, et al. Blood Purification with oXiris© in Critically Ill Children with Vasoplegic Shock. Blood Purification. 2023. doi:10.1159/000530147
BibTeX
@article{Morin2023,
author = {Morin, Luc and Charbel, Ramy and Cousin, Vladimir L and Marais, Clémence and Claude, Caroline and Barreault, Simon and Durand, Philippe and Miatello, Jordi and Tissières, Pierre},
title = {Blood Purification with oXiris© in Critically Ill Children with Vasoplegic Shock},
journal = {Blood Purification},
year = {2023},
doi = {10.1159/000530147}
}
EUVIMED